Far-UVC Borosilicate Lamp Cover for Safe MRSA Eradication

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing UVGI methods using conventional germicidal UV lamps are harmful to human skin and eyes, and are not suitable for direct treatment of MRSA on mammalian skin due to skin- and eye-damaging effects.

Innovation Solution

The use of UV-transparent borosilicate glasses that allow for the transmission of far-UVC light in the range of 207 nm to 222 nm, which is effective in eradicating MRSA without causing damage to human skin or eyes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional germicidal UV lamps (254 nm) are used for MRSA eradication, then disinfection effectiveness is improved, but skin and eye damage occurs

Engineering Contradiction:
Improvedisinfection effectivenessVSAvoidskin and eye damage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the wavelength parameter of UV light from conventional 254 nm to far-UVC range (207-222 nm). This parameter change enables the light to maintain germicidal effectiveness against MRSA while reducing penetration depth into human tissues, thereby eliminating skin and eye damage associated with conventional UV lamps

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces UV-transparent borosilicate glass as an intermediary material in the lamp cover. This glass selectively transmits far-UVC wavelengths (207-222 nm) while blocking harmful longer wavelengths, acting as a mediator that allows beneficial UV radiation to pass through while filtering out harmful components

Inventive Principle:
Principle #24Intermediary (Mediator)

2Illumination intensity

If UV-transparent borosilicate glass is used in lamp covers, then far-UVC transmission (207-222 nm) is improved, but manufacturing precision requirements increase

Engineering Contradiction:
Improvefar-UVC transmissionVSAvoidglass composition control
Core Design Contradiction:
Illumination intensityVSManufacturing precision

Solution Approach 1:

The patent specifies precise compositional parameters for borosilicate glass (SiO2: 70-77 wt%, B2O3: 10-20 wt%, with controlled Fe2O3 and TiO2 content). By defining these parameter ranges, the patent enables manufacturers to produce glass with consistent far-UVC transmission properties while managing manufacturing precision requirements through clear specification limits

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves a 90% reduction of MRSA with UV exposure in the range of 2,000 to 8,000 µW·s/cm², while minimizing harm to human tissues.

Implementation Method 1

UVGI is used in a variety of applications, such as food, air, and water purification. UVGI devices can produce strong enough UVC light in circulating air or water systems to make them inhospitable environments to microorganisms such as bacteria, viruses, molds and other pathogens. The application of UVGI to disinfection has been an accepted practice since the mid-20th century.

Methodology Applied
Scientific EffectUltraviolet germicidal irradiation: Absorption (EM radiation)

Implementation Method 2

UV-absorption of UV-light at wavelengths of about 200 nm to about 250 nm is very high in otherwise transparent covers. Conventional borosilicate glasses do not transmit light at wavelengths below 290 nm. However, it has been reported that far-UVC-light kills bacteria efficiently regardless of their drug-resistant proficiency, but without the skin- or eye-damaging effects associated with conventional germicidal UV exposure.

Methodology Applied
Scientific EffectSelective UV transmission: Absorption (EM radiation)

Data Source

PatentEP3960206B1Method for eradicating methicillin-resistant staphylococcus aureus
Publication Date: 2025.02.19 SCHOTT AG
  • EP3960206B1 patent drawingFigure 1
  • EP3960206B1 patent drawingFigure 2a~2f
  • EP3960206B1 patent drawingFigure 3a~3e

AI summary

The present invention relates to methods for eradication Methicillin-resistant Staphylococcus aureus (MRSA), especially to methods for eradicating MRSA from UV-sensitive surfaces. The method comprises the use of germicidal UV light within the wavelength range of from 207 nm to 222 nm, wherein the UV light is irradiated by a UV lamp having a lamp cover made of specific UV-permitting borosilicate glasses. The present invention includes uses of such UV-permitting glasses as well methods for making the same.